JP2015194481A5 - - Google Patents

Download PDF

Info

Publication number
JP2015194481A5
JP2015194481A5 JP2015040187A JP2015040187A JP2015194481A5 JP 2015194481 A5 JP2015194481 A5 JP 2015194481A5 JP 2015040187 A JP2015040187 A JP 2015040187A JP 2015040187 A JP2015040187 A JP 2015040187A JP 2015194481 A5 JP2015194481 A5 JP 2015194481A5
Authority
JP
Japan
Prior art keywords
protein
fabp4
fabp5
expression level
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015040187A
Other languages
English (en)
Japanese (ja)
Other versions
JP6223376B2 (ja
JP2015194481A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2015040187A external-priority patent/JP6223376B2/ja
Priority to JP2015040187A priority Critical patent/JP6223376B2/ja
Priority to EP15769760.8A priority patent/EP3124966B1/en
Priority to US15/128,666 priority patent/US10132795B2/en
Priority to CN201580015560.7A priority patent/CN106133519B/zh
Priority to PCT/JP2015/056603 priority patent/WO2015146537A1/ja
Publication of JP2015194481A publication Critical patent/JP2015194481A/ja
Publication of JP2015194481A5 publication Critical patent/JP2015194481A5/ja
Publication of JP6223376B2 publication Critical patent/JP6223376B2/ja
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015040187A 2014-03-24 2015-03-02 Ｇｉｐ上昇抑制剤の評価又は選択方法 Expired - Fee Related JP6223376B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2015040187A JP6223376B2 (ja) 2014-03-24 2015-03-02 Ｇｉｐ上昇抑制剤の評価又は選択方法
PCT/JP2015/056603 WO2015146537A1 (ja) 2014-03-24 2015-03-06 Ｇｉｐ上昇抑制剤の評価又は選択方法
US15/128,666 US10132795B2 (en) 2014-03-24 2015-03-06 Method for evaluating or selecting agent for suppressing GIP level elevation
CN201580015560.7A CN106133519B (zh) 2014-03-24 2015-03-06 Gip上升抑制剂的评价或选择方法
EP15769760.8A EP3124966B1 (en) 2014-03-24 2015-03-06 Method for evaluating or selecting agent for suppressing gip level elevation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014060341 2014-03-24
JP2014060341 2014-03-24
JP2015040187A JP6223376B2 (ja) 2014-03-24 2015-03-02 Ｇｉｐ上昇抑制剤の評価又は選択方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017144146A Division JP6514282B2 (ja) 2014-03-24 2017-07-26 Ｇｉｐ上昇抑制剤の評価又は選択方法

Publications (3)

Publication Number Publication Date
JP2015194481A JP2015194481A (ja) 2015-11-05
JP2015194481A5 true JP2015194481A5 (enExample) 2017-04-06
JP6223376B2 JP6223376B2 (ja) 2017-11-01

Family

ID=54195063

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015040187A Expired - Fee Related JP6223376B2 (ja) 2014-03-24 2015-03-02 Ｇｉｐ上昇抑制剤の評価又は選択方法

Country Status (5)

Country Link
US (1) US10132795B2 (enExample)
EP (1) EP3124966B1 (enExample)
JP (1) JP6223376B2 (enExample)
CN (1) CN106133519B (enExample)
WO (1) WO2015146537A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6677455B2 (ja) * 2015-05-14 2020-04-08 花王株式会社 毛成長抑制剤の評価又は選択方法
CN114981446A (zh) * 2020-01-17 2022-08-30 日本乐敦制药株式会社 组织形态、组织功能控制剂的评价/筛选方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5518798A (en) 1996-12-03 1998-06-29 Trustees Of Boston University Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)
US7358254B2 (en) 2001-07-13 2008-04-15 Bristol-Myers Squibb Company Method for treating atherosclerosis employing an aP2 inhibitor and combination
DE69939481D1 (de) * 1998-09-17 2008-10-16 Bristol Myers Squibb Co Methode zur behandlung von diabetes die einen ap2-inhibitor und dazugehörige kombinationen verwendet
US6831102B2 (en) * 2001-12-07 2004-12-14 Bristol-Myers Squibb Company Phenyl naphthol ligands for thyroid hormone receptor
JP2004065194A (ja) * 2002-08-09 2004-03-04 Sumitomo Chem Co Ltd 脂肪細胞関連因子の分析方法
EP2898898B1 (en) 2009-03-05 2025-09-10 President and Fellows of Harvard College Secreted AP2 and methods of inhibiting same
WO2011007864A1 (ja) * 2009-07-16 2011-01-20 花王株式会社 血中ｇｉｐ濃度上昇抑制剤
JP5317919B2 (ja) 2009-10-05 2013-10-16 花王株式会社 Ｇｉｐ上昇抑制剤の評価又は選択方法
JP5328595B2 (ja) 2009-10-05 2013-10-30 花王株式会社 Ｇｉｐ上昇抑制剤の評価又は選択方法
WO2012096108A1 (ja) * 2011-01-12 2012-07-19 花王株式会社 血中ｇｉｐ濃度上昇抑制剤、血中インスリン濃度上昇抑制剤、食後血中トリグリセリド濃度低減剤、及び血糖濃度上昇抑制剤
JP6026723B2 (ja) 2011-02-22 2016-11-16 花王株式会社 Ｇｉｐ上昇抑制剤
JP2012171914A (ja) 2011-02-22 2012-09-10 Kao Corp Ｇｉｐ上昇抑制剤
CN102961388A (zh) * 2011-08-30 2013-03-13 三和淀粉工业株式会社 促进glp-1的分泌并且抑制gip的分泌的药剂

Similar Documents

Publication Publication Date Title
CY1123391T1 (el) (2s)-n-[(1s)-1-kyano-2-φainyλaιθyλ]-1,4-oξazeπan-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης ι
WO2018132739A3 (en) T cell receptors that bind to ny-eso-1 and methods of use thereof
JP2017048194A5 (enExample)
WO2015176066A3 (en) Lpa-associated protein and rna expression
JP2017526437A5 (ja) 遠隔虚血コンディショニングを行うシステムが組み込まれている医療装置、医療装置を動作させる方法、コンピュータ可読記憶媒体、台、及び自動体外式除細動器
JP2014144959A5 (enExample)
MX392538B (es) Acidos 3-alquil-4-amido-biciclico [4,5,0] hidroxamicos como inhibidores de histona desacetilasas (hdac)
WO2013011479A3 (en) Assessment of cellular signaling pathway activity using probabilistic modeling of target gene expression
MX2016002879A (es) Sistemas, dispositivos y metodos para la terapia anti-tl1a.
MX2017014730A (es) Muteinas de lipocalina 2 humana con afinidad por glipicano-3 (gpc3).
AR092981A1 (es) Biomarcadores predictivos de la respuesta clinica al acetato de glatiramero
JP2017039729A5 (enExample)
WO2017132557A3 (en) Prediction of therapeutic response in inflammatory conditions
BR112017001971A2 (pt) ?métodos e composições para diagnosticar e tratar distúrbios inflamatórios intestinais?
JP2016521114A5 (enExample)
JP2016509026A5 (enExample)
JP2014080432A5 (enExample)
JP2016516985A5 (enExample)
JP2016528914A5 (enExample)
JP2015194481A5 (enExample)
JP2014209129A5 (enExample)
JP2015530094A5 (enExample)
JP2016527901A5 (enExample)
WO2015074010A3 (en) Compositions and methods for cardiac regeneration
EA201501137A1 (ru) Биомаркеры генной экспрессии и их использование для диагностического и прогностического применения у пациентов, потенциально нуждающихся в лечении ингибитором hdac